Foxx Development (NASDAQ:FOXX) Issues Quarterly Earnings Results

Foxx Development (NASDAQ:FOXX) announced its quarterly earnings data on Friday. The company reported ($0.62) EPS for the quarter, FiscalAI reports. The company had revenue of $16.72 million for the quarter.

Foxx Development Trading Down 2.2%

Shares of FOXX opened at $4.94 on Friday. Foxx Development has a twelve month low of $1.71 and a twelve month high of $8.88. The firm has a market capitalization of $33.50 million, a P/E ratio of -2.19 and a beta of -0.21. The firm’s 50-day moving average is $4.56 and its two-hundred day moving average is $4.79.

Hedge Funds Weigh In On Foxx Development

A hedge fund recently raised its stake in Foxx Development stock. JPMorgan Chase & Co. increased its position in shares of Foxx Development Holdings Inc. (NASDAQ:FOXX) by 170.9% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 4,947 shares of the company’s stock after purchasing an additional 3,121 shares during the quarter. JPMorgan Chase & Co. owned 0.07% of Foxx Development worth $27,000 as of its most recent filing with the SEC. Institutional investors own 60.44% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Foxx Development in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Foxx Development presently has an average rating of “Sell”.

Foxx Development Company Profile

Foxx Development, Inc (NASDAQ: FOXX) operates as a contract manufacturer specializing in the design, assembly and distribution of medical devices and components. The company’s core business centers on phlebotomy and blood collection products, serving clinical laboratories, hospitals and diagnostic testing facilities. Its product portfolio includes evacuated blood collection tubes, safety-engineered winged blood collection sets, syringes and ancillary devices used in specimen collection and handling.

Founded in North Carolina, Foxx Development maintains a manufacturing and distribution campus in Apex, where it integrates engineering, quality control and regulatory compliance under one roof.